DePuy Synthes’ hardware can be found in a huge share of the orthopedic and trauma procedures done in the U.S. every year, which means a change in ownership could have real downstream implications for physicians. Here’s why:
- Trauma surgeons may be the most exposed. Johnson & Johnson DePuy holds more than 45% of the global trauma implant market — a commanding lead over any competitor. By comparison, DePuy Synthes ranks third in both the knee and hip reconstruction markets, behind Zimmer Biomet and Stryker. That means orthopedic trauma surgeons, who often depend on whichever hardware their hospital has on-shelf for urgent fracture repair, are more reliant on DePuy Synthes specifically than any other physician group.
- Device reps play an outsized role in case coverage. Medical device reps stock trays, provide in-OR technical support, and coordinate on-call coverage for urgent trauma and spine cases. Physicians who work regularly with DePuy Synthes reps have built those relationships around this specific level of support.
- DePuy Synthes is a major player in orthopedic innovation. The company has been actively expanding its Velys robotic platform, adding a partial knee application in 2024 and a spine application in 2025, on top of its original total knee system. It’s one of a handful of companies (alongside Stryker, Zimmer Biomet and Smith & Nephew) driving robotic-assisted surgery adoption.
- The company carries legacy liability tied to past products. DePuy recalled all ASR hip implant systems sold since 2003 back in 2010, and the unit has faced thousands of lawsuits over hip replacement devices since. That history includes established infrastructure for warranty support, device tracking and litigation response for physicians managing revision cases on older devices.
- Hospitals typically have multi-year pricing and volume agreements with DePuy Synthes. These agreements, often bundled into broader J&J contracts, shape which implants are on a hospital’s formulary and what physicians have access to in the OR.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
